Top Key Companies for mRNA Drug Market: Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca, Janssen.
Global mRNA Drug Market Size was estimated at USD 4862.14 million in 2022 and is projected to reach USD 6460.08 million by 2028, exhibiting a CAGR of 4.85% during the forecast period.
Global mRNA Drug Market Overview And Scope:
The Global mRNA Drug Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of mRNA Drug utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global mRNA Drug Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global mRNA Drug market.
Global mRNA Drug Market Segmentation
By Type, mRNA Drug market has been segmented into:
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
By Application, mRNA Drug market has been segmented into:
Hospital
Clinic
Regional Analysis of mRNA Drug Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of mRNA Drug Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The mRNA Drug market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the mRNA Drug market.
Top Key Companies Covered in mRNA Drug market are:
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: mRNA Drug Market by Type
5.1 mRNA Drug Market Overview Snapshot and Growth Engine
5.2 mRNA Drug Market Overview
5.3 Preventive Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Preventive Vaccines: Geographic Segmentation
5.4 Therapeutic Vaccine
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Therapeutic Vaccine: Geographic Segmentation
5.5 Therapeutic Drugs
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Therapeutic Drugs: Geographic Segmentation
Chapter 6: mRNA Drug Market by Application
6.1 mRNA Drug Market Overview Snapshot and Growth Engine
6.2 mRNA Drug Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Clinic
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinic: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 mRNA Drug Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 mRNA Drug Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 mRNA Drug Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MODERNA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PFIZER
7.4 ZYDUS CADILA
7.5 FOSUN PHARMA
7.6 CUREVAC
7.7 SRI LANKAN MICROORGANISMS
7.8 BIONTECH
7.9 ASTRAZENECA
7.10 JANSSEN
Chapter 8: Global mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Preventive Vaccines
8.2.2 Therapeutic Vaccine
8.2.3 Therapeutic Drugs
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Clinic
Chapter 9: North America mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Preventive Vaccines
9.4.2 Therapeutic Vaccine
9.4.3 Therapeutic Drugs
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Clinic
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Preventive Vaccines
10.4.2 Therapeutic Vaccine
10.4.3 Therapeutic Drugs
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Clinic
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Preventive Vaccines
11.4.2 Therapeutic Vaccine
11.4.3 Therapeutic Drugs
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Clinic
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Preventive Vaccines
12.4.2 Therapeutic Vaccine
12.4.3 Therapeutic Drugs
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Clinic
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Preventive Vaccines
13.4.2 Therapeutic Vaccine
13.4.3 Therapeutic Drugs
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Clinic
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America mRNA Drug Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Preventive Vaccines
14.4.2 Therapeutic Vaccine
14.4.3 Therapeutic Drugs
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Clinic
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
mRNA Drug Scope:
|
Report Data
|
mRNA Drug Market
|
|
mRNA Drug Market Size in 2025
|
USD XX million
|
|
mRNA Drug CAGR 2025 - 2032
|
XX%
|
|
mRNA Drug Base Year
|
2024
|
|
mRNA Drug Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca, Janssen.
|
|
Key Segments
|
By Type
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
By Applications
Hospital
Clinic
|
